Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 38B | 29.6B | 23.7B | 30.6B |
Cost of revenue | 4.2B | 7.7B | 2.6B | 5.9B |
Gross profit | 33.8B | 21.9B | 21.0B | 24.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.0B | -3.6B | 1.7B | 1.7B |
Operating income | 22.8B | 16.3B | 12.9B | 16.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 15.3B | 10.8B | 9.4B | 13.7B |
Other income expense | — | — | — | — |
Pretax income | 9.4B | 8.5B | 2.9B | 4.4B |
Tax provision | 2.3B | 1.2B | -1.1B | 260M |
Net income | 8.2B | 3.8B | 4.7B | 5.2B |
Basic EPS | 4.3 | — | 2.9 | 1.6 |
Diluted EPS | 4.3 | — | 2.9 | 1.5 |
Basic average shares | 1.7B | — | 1.7B | 1.8B |
Diluted average shares | 1.7B | — | 1.7B | 1.8B |
EBITDA | 32.5B | 23.5B | 18.7B | 25.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | -1.1B | -1.5B | 180M | -2.4B |
Preferred stock dividends | 0 | 1.2B | 0 | 0 |